BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18020912)

  • 1. Genomic signatures individualize therapeutic decisions in non-small-cell lung cancer.
    Anguiano A; Potti A
    Expert Rev Mol Diagn; 2007 Nov; 7(6):837-44. PubMed ID: 18020912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling of non-small-cell lung cancer.
    Lacroix L; Commo F; Soria JC
    Expert Rev Mol Diagn; 2008 Mar; 8(2):167-78. PubMed ID: 18366303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular profiling of non-small cell lung cancer: of what value in clinical practice?
    Newnham GM; Thomas DM; McLachlan SA; Wright G; Conron M
    Heart Lung Circ; 2008 Dec; 17(6):451-62. PubMed ID: 18676201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding prognostic gene expression signatures in lung cancer.
    Zhu CQ; Pintilie M; John T; Strumpf D; Shepherd FA; Der SD; Jurisica I; Tsao MS
    Clin Lung Cancer; 2009 Sep; 10(5):331-40. PubMed ID: 19808191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
    J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer.
    Raponi M; Dossey L; Jatkoe T; Wu X; Chen G; Fan H; Beer DG
    Cancer Res; 2009 Jul; 69(14):5776-83. PubMed ID: 19584273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mining gene expression profiles: expression signatures as cancer phenotypes.
    Nevins JR; Potti A
    Nat Rev Genet; 2007 Aug; 8(8):601-9. PubMed ID: 17607306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microarrays in breast cancer research and clinical practice--the future lies ahead.
    Gruvberger-Saal SK; Cunliffe HE; Carr KM; Hedenfalk IA
    Endocr Relat Cancer; 2006 Dec; 13(4):1017-31. PubMed ID: 17158752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes.
    Kuner R; Muley T; Meister M; Ruschhaupt M; Buness A; Xu EC; Schnabel P; Warth A; Poustka A; Sültmann H; Hoffmann H
    Lung Cancer; 2009 Jan; 63(1):32-8. PubMed ID: 18486272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of clinical outcome in multiple lung cancer cohorts by integrative genomics: implications for chemotherapy selection.
    Broët P; Camilleri-Broët S; Zhang S; Alifano M; Bangarusamy D; Battistella M; Wu Y; Tuefferd M; Régnard JF; Lim E; Tan P; Miller LD
    Cancer Res; 2009 Feb; 69(3):1055-62. PubMed ID: 19176396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management.
    Glinsky GV
    J Clin Oncol; 2008 Jun; 26(17):2846-53. PubMed ID: 18539963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
    Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular biologic staging of lung cancer.
    D'Amico TA
    Ann Thorac Surg; 2008 Feb; 85(2):S737-42. PubMed ID: 18222207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic medicine in non-small cell lung cancer: paving the path to personalized care.
    Sriram KB; Larsen JE; Yang IA; Bowman RV; Fong KM
    Respirology; 2011 Feb; 16(2):257-63. PubMed ID: 21044232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: Gene expression-based prognostic signatures in lung cancer: ready for clinical use?
    Boutros PC; Pintilie M; John T; Starmans MH; Der SD; Shepherd FA; Tsao MS; Jurisica I
    J Natl Cancer Inst; 2010 Nov; 102(21):1677-8; author reply 1678-9. PubMed ID: 20921041
    [No Abstract]   [Full Text] [Related]  

  • 16. An immune response enriched 72-gene prognostic profile for early-stage non-small-cell lung cancer.
    Roepman P; Jassem J; Smit EF; Muley T; Niklinski J; van de Velde T; Witteveen AT; Rzyman W; Floore A; Burgers S; Giaccone G; Meister M; Dienemann H; Skrzypski M; Kozlowski M; Mooi WJ; van Zandwijk N
    Clin Cancer Res; 2009 Jan; 15(1):284-90. PubMed ID: 19118056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers of response to epidermal growth factor receptor inhibitors in Non-Small-Cell Lung Cancer Working Group: standardization for use in the clinical trial setting.
    Eberhard DA; Giaccone G; Johnson BE;
    J Clin Oncol; 2008 Feb; 26(6):983-94. PubMed ID: 18281673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of differential gene expression profiles of radioresistant lung cancer cell line established by fractionated ionizing radiation in vitro.
    Xu QY; Gao Y; Liu Y; Yang WZ; Xu XY
    Chin Med J (Engl); 2008 Sep; 121(18):1830-7. PubMed ID: 19080366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling in breast cancer.
    Morris SR; Carey LA
    Curr Opin Oncol; 2007 Nov; 19(6):547-51. PubMed ID: 17906450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression-based prognostic signatures in lung cancer: ready for clinical use?
    Subramanian J; Simon R
    J Natl Cancer Inst; 2010 Apr; 102(7):464-74. PubMed ID: 20233996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.